Table 3.
Post-hoc tests examining the above 3×2×3 interactions
Region | Side | Post Hoc test | Condition | t | df | P | F |
---|---|---|---|---|---|---|---|
Caudate | L | ATT>HC | CD3 | 3.48 | 27 | 0.002 | 11.98 |
NAT>HC | CD3 | 2.09 | 26 | 0.047 | 4.34 | ||
Middle Temporal Gyrus (BA39) | L | NAT>ATT | AB1 | 2.87 | 28 | 0.008 | 8.18 |
NAT>ATT | AB3 | 2.36 | 28 | 0.026 | 5.53 | ||
NAT>ATT | CD2 | 2.78 | 28 | 0.010 | 7.66 | ||
ATT>HC | CD3 | 2.39 | 27 | 0.025 | 5.67 | ||
NAT>HC | AB1 | 2.69 | 26 | 0.013 | 7.17 | ||
NAT>HC | AB3 | 2.35 | 26 | 0.027 | 5.48 | ||
NAT>HC | CD2 | 3.23 | 26 | 0.003 | 10.35 | ||
NAT>HC | CD3 | 2.58 | 26 | 0.016 | 6.61 | ||
Hippocampus | L | NAT>ATT | CD2 | 2.96 | 28 | 0.006 | 8.72 |
ATT>HC | AB2 | 2.20 | 27 | 0.037 | 4.84 | ||
ATT>HC | CD3 | 2.76 | 27 | 0.010 | 7.57 | ||
NAT>HC | AB1 | 2.32 | 26 | 0.029 | 5.35 | ||
NAT>HC | AB2 | 3.13 | 26 | 0.004 | 9.69 | ||
NAT>HC | AB3 | 2.56 | 26 | 0.017 | 6.53 | ||
NAT>HC | CD2 | 4.05 | 26 | 0.0004 | 16.25 | ||
NAT>HC | CD3 | 3.31 | 26 | 0.003 | 10.84 | ||
Medial Frontal Gyrus (BA10) | R | NAT>ATT | AB3 | 2. 27 | 28 | 0.031 | 5.14 |
ATT>HC | CD1 | 2.35 | 27 | 0.027 | 5.48 | ||
NAT>HC | AB3 | 3.14 | 26 | 0.004 | 9.79 | ||
Thalamus | R | NAT>ATT | AB3 | 3. 61 | 28 | 0.001 | 12.93 |
NAT>HC | AB3 | 2.32 | 26 | 0.029 | 5.35 | ||
Fusiform Gyrus (BA37) | L | ATT>HC | CD3 | 2.52 | 27 | 0.018 | 6.33 |
Occipital Gyrus (BA19) | R | HC>ATT | CD2 | 2.43 | 27 | 0.022 | 5.88 |
For Condition, AB=high risk, CD=low risk, Numeral=block (e.g. AB=high risk choices in block 1)